BSE - Delayed Quote INR

HealthCare Global Enterprises Limited (HCG.BO)

547.65
+2.90
+(0.53%)
At close: June 13 at 3:28:01 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
22,181,400
22,181,400
19,078,700
16,760,470
13,831,380
Cost of Revenue
10,622,700
10,622,700
8,889,900
7,997,550
6,820,730
Gross Profit
11,558,700
11,558,700
10,188,800
8,762,920
7,010,650
Operating Expense
9,799,300
9,799,300
8,636,500
7,109,640
6,236,200
Operating Income
1,759,400
1,759,400
1,552,300
1,653,280
774,450
Net Non Operating Interest Income Expense
-1,545,600
-1,545,600
-1,087,400
-866,680
-828,050
Pretax Income
569,600
569,600
677,200
448,800
877,720
Tax Provision
81,300
81,300
264,000
272,500
488,470
Net Income Common Stockholders
444,100
444,100
481,400
293,490
537,330
Diluted NI Available to Com Stockholders
444,100
444,100
481,400
293,490
537,330
Basic EPS
3.19
--
3.46
2.11
4.14
Diluted EPS
3.14
--
3.43
2.10
3.97
Basic Average Shares
139,216.30
--
139,132.95
139,073.79
129,707.61
Diluted Average Shares
141,433.12
--
140,349.85
139,073.79
135,182.43
Rent Expense Supplemental
--
--
218,400
111,550
92,800
Total Expenses
20,422,000
20,422,000
17,526,400
15,107,190
13,056,930
Net Income from Continuing & Discontinued Operation
444,100
444,100
481,400
293,490
537,330
Normalized Income
444,100
444,100
457,603.78
521,774
-121,307
Interest Income
--
--
126,970
118,100
115,610
Interest Expense
1,545,600
1,545,600
1,087,400
914,730
838,870
Net Interest Income
-1,545,600
-1,545,600
-1,087,400
-866,680
-828,050
EBIT
2,115,200
2,115,200
1,764,600
1,363,530
1,716,590
EBITDA
4,228,600
4,228,600
3,508,200
2,998,260
3,299,430
Reconciled Cost of Revenue
10,622,700
10,622,700
8,889,900
7,997,550
6,820,730
Reconciled Depreciation
2,113,400
2,113,400
1,743,600
1,634,730
1,582,840
Net Income from Continuing Operation Net Minority Interest
444,100
444,100
481,400
293,490
537,330
Total Unusual Items Excluding Goodwill
0
0
39,000
-326,120
940,910
Total Unusual Items
0
0
39,000
-326,120
940,910
Normalized EBITDA
4,228,600
4,228,600
3,469,200
3,324,380
2,358,520
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
15,203.78
-97,836
282,273
3/31/2022 - 3/30/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade